511 related articles for article (PubMed ID: 26395218)
21. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan.
Hsueh SC; Lee YJ; Huang YT; Liao CH; Tsuji M; Hsueh PR
J Antimicrob Chemother; 2019 Feb; 74(2):380-386. PubMed ID: 30357343
[TBL] [Abstract][Full Text] [Related]
22. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
Mohanty S; Maurya V; Gaind R; Deb M
J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
[TBL] [Abstract][Full Text] [Related]
24. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
[TBL] [Abstract][Full Text] [Related]
25. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
[TBL] [Abstract][Full Text] [Related]
26. Performances of the Rapid Polymyxin
Lescat M; Poirel L; Jayol A; Nordmann P
Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
[No Abstract] [Full Text] [Related]
27. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
28. Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media.
Matzneller P; Strommer S; Österreicher Z; Mitteregger D; Zeitlinger M
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1989-94. PubMed ID: 26178070
[TBL] [Abstract][Full Text] [Related]
29. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates.
Owen RJ; Li J; Nation RL; Spelman D
J Antimicrob Chemother; 2007 Mar; 59(3):473-7. PubMed ID: 17289768
[TBL] [Abstract][Full Text] [Related]
30. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
[TBL] [Abstract][Full Text] [Related]
31. Effect of combined colistin and meropenem against meropenem resistant
Gunalan A; Sarumathi D; Sastry AS; Ramanathan V; Rajaa S; Sistla S
Indian J Pharmacol; 2021; 53(3):207-212. PubMed ID: 34169905
[TBL] [Abstract][Full Text] [Related]
32. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
Chin JN; Jones RN; Sader HS; Savage PB; Rybak MJ
J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of RX-P873 against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii.
Flamm RK; Rhomberg PR; Jones RN; Farrell DJ
Antimicrob Agents Chemother; 2015 Apr; 59(4):2280-5. PubMed ID: 25645834
[TBL] [Abstract][Full Text] [Related]
34. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the rapid ResaPolymyxin
Jung H; Pitout JDD; Mitton BC; Strydom KA; Kingsburgh C; Coetzee J; Ehlers MM; Kock M
J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34165418
[No Abstract] [Full Text] [Related]
36. Time-kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin.
Safarika A; Galani I; Pistiki A; Giamarellos-Bourboulis EJ
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):317-23. PubMed ID: 25192733
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group.
Conlon JM; Sonnevend A; Pál T; Vila-Farrés X
Int J Antimicrob Agents; 2012 Apr; 39(4):317-20. PubMed ID: 22326566
[TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
[TBL] [Abstract][Full Text] [Related]
39. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
[TBL] [Abstract][Full Text] [Related]
40. In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
Bozkurt-Guzel C; Savage PB; Gerceker AA
Chemotherapy; 2011; 57(6):505-10. PubMed ID: 22286090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
